EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Economic Evaluation of the InTENSE Program of Therapy Alongside Botulinum Neurotoxin a for the Rehabilitation of Chronic Upper Limb Spasticity

Rachel Milte, Jia Song iD, Sean Docking iD, Julie Ratcliffe, Ian D Cameron iD, Maria Crotty, Louise Ada iD, Coralie English iD, Natasha A Lannin iD

Toxins · 2025

DOI: 10.3390/toxins17070341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, 2025. Verfasst von Rachel Milte und 8 weiteren Autor:innen. Beteiligte Einrichtung: Caring Futures Institute, Flinders University, Adelaide, SA 5001, Australia. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Muscle Spasticity, Upper Extremity, Neuromuscular Agents. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, National Heart Foundation of Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spasticity is a persistent and debilitating consequence of stroke and effective rehabilitation is a healthcare priority. Botulinum neurotoxin A (BoNT-A) with supportive therapy has increasingly been embedded within clinical practice for treatment of post-stroke spasticity. But the evidence for this approach has hitherto been limited to the findings of a limited number of small trials. The InTENSE trial was undertaken specifically to provide high-quality clinical trial evidence focusing on the effect of BoNT-A and adjunctive therapy on upper limb spasticity. While the clinical trial did not detect a significant impact upon clinical outcomes, there remains a need to evaluate any impact on the broader use of healthcare resources and overall cost-effectiveness. A detailed cost–utility analysis of the InTENSE trial was undertaken. The costs over the 12-month follow-up period were compared with quality-adjusted life years (QALY) gained using utilities generated from the EQ-5D three level (EQ-5D-3L) instrument. There were no significant differences in QALY gained between the intervention and control groups identified, or in the majority of health and community care costs. The Incremental Cost-Effectiveness Ratio per QALY gained was estimated at AU $63,947.11 (Australian dollars), which is well above accepted thresholds for cost-effectiveness in Australia. The study was unable to identify evidence for the cost-effectiveness of treatment approaches combining BoNT-A with adjunctive therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type AMuscle SpasticityUpper ExtremityNeuromuscular AgentsStroke RehabilitationHumansCost-Benefit AnalysisQuality-Adjusted Life YearsMaleFemaleMiddle AgedChronic DiseaseStrokeTreatment OutcomeAged

Stichwörter der Autor:innen

botulinum neurotoxin Acost-effectiveness analysiscostscost–utility analysiseconomic evaluationrehabilitationstroke

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Caring Futures Institute, Flinders University, Adelaide, SA 5001, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia.
  • Sydney School of Health Sciences, University of Sydney, Sydney, NSW 2006, Australia.
  • College of Medicine and Public Health, Flinders University, Adelaide, SA 5001, Australia.
  • School of Health Sciences, University of Newcastle, Callaghan, NSW 2308, Australia.
  • Department of Neuroscience, Monash University, Alfred Health, Melbourne, VIC 304, Australia.

ORCID-Profile: Jia Song, Sean Docking, Ian D Cameron, Louise Ada, Coralie English, Natasha A Lannin

Förderung

  • National Health and Medical Research Council
  • National Heart Foundation of Australia

Zitieren

APA

Milte, R., Song, J., Docking, S., Ratcliffe, J., Cameron, I. D., Crotty, M., Ada, L., English, C., & Lannin, N. A. (2025). Economic Evaluation of the InTENSE Program of Therapy Alongside Botulinum Neurotoxin a for the Rehabilitation of Chronic Upper Limb Spasticity. Toxins. https://doi.org/10.3390/toxins17070341

Vancouver

Milte R, Song J, Docking S, Ratcliffe J, Cameron ID, Crotty M, et al. Economic Evaluation of the InTENSE Program of Therapy Alongside Botulinum Neurotoxin a for the Rehabilitation of Chronic Upper Limb Spasticity. Toxins. 2025. doi:10.3390/toxins17070341

BibTeX
@article{Milte2025,
  author = {Milte, Rachel and Song, Jia and Docking, Sean and Ratcliffe, Julie and Cameron, Ian D and Crotty, Maria and Ada, Louise and English, Coralie and Lannin, Natasha A},
  title = {Economic Evaluation of the InTENSE Program of Therapy Alongside Botulinum Neurotoxin a for the Rehabilitation of Chronic Upper Limb Spasticity},
  journal = {Toxins},
  year = {2025},
  doi = {10.3390/toxins17070341}
}
Kostenlos starten →